Evidence map›Paper›PMID 37434183›Full record

ArticleImmunity & ageing : I & A2023

Blood RNA-Seq profiling reveals a set of circular RNAs differentially expressed in frail individuals.

Leire Iparraguirre, Ainhoa Alberro, Saioa Gs Iñiguez, Maider Muñoz-Culla, Itziar Vergara, Ander Matheu, David Otaegui

Open access · goldAbstract read
In one paragraph

Article in Immunity & ageing : I & A, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Leire IparraguirreMultiple Sclerosis Unit. Biodonostia Health Research Institute, 20014, San Sebastián, Spain.
Ainhoa AlberroMultiple Sclerosis Unit. Biodonostia Health Research Institute, 20014, San Sebastián, Spain.
Saioa Gs IñiguezMultiple Sclerosis Unit. Biodonostia Health Research Institute, 20014, San Sebastián, Spain.
Maider Muñoz-CullaMultiple Sclerosis Unit. Biodonostia Health Research Institute, 20014, San Sebastián, Spain.
Itziar VergaraGroup of Research in Primary Care. Biodonostia Health Research Institute, 20014, San Sebastián, Spain.
Ander MatheuCellular oncology group. Biodonostia Health Research Institute, 20014, San Sebastián, Spain.
David OtaeguiMultiple Sclerosis Unit. Biodonostia Health Research Institute, 20014, San Sebastián, Spain. david.otaegui@biodonostia.org.
Biogipuzkoa Health Research Institute · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable · ESUniversity of the Basque Country · ES

Funding

Hezkuntza, Hizkuntza Politika Eta Kultura Saila, Eusko Jaurlaritza POS_2021_0008
6 · The paper itself

Abstract

backgroundFrailty is an intermediate and reversible geriatric syndrome that often precedes dependence. Therefore, its identification is essential to prevent dependence. Several molecules have been proposed as biomarkers of frailty, but none of them have reached clinical practice. Recently, circular RNAs have emerged as new non-coding RNAs. Their regulatory role together with their high stability in biofluids makes them good candidates as biomarkers for various processes, but, to date, no study has characterized the expression of circRNA in frailty.

resultsWe studied RNA from leukocytes of 35 frails and 35 robust individuals. After RNA-Sequencing, circRNA detection was performed by CIRI2 and Circexplorer2 and differential expression analysis by DESeq2. Validation was performed by Quantitative-PCR. Linear Discriminant Analysis was performed to determine the best circRNA combination to discriminate frail from robust. In addition, CircRNA candidates were studied in 13 additional elder donors before and after a 3-month physical intervention. We found 89 differentially expressed circRNAs (p-value<0.05, FC>|1.5|) with frailty. Upregulation of hsa_circ_0007817, hsa_circ_0101802 and hsa_circ_0060527 in frail individuals was validated. The combination of hsa_circ_0079284, hsa_circ_0007817 and hsa_circ_0075737 levels showed a great biomarker value with a 95.9% probability of correctly classifying frail and robust individuals. Moreover, hsa_circ_0079284 levels decreased after physical intervention in concordance with an improvement in frailty scores.

conclusionsThis work describes for the first time a different expression pattern of circular RNA (circRNAs) between frail and robust individuals. Moreover, the level of some circRNAs is modulated after a physical intervention. These results suggest that they could be used as minimally invasive biomarkers of frailty.

Indexed as

BiomarkerCircular RNAFrailty

Identifiers

PMID37434183
PMCPMC10334614
OpenAlexW4383877710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.